Sulfonylureas may need dose reduction during weeks 1 to 2 when overlapping drug levels increase hypoglycemia risk
Central and peripheral nervous system models in rats covering traumatic injury, stroke, and peripheral nerve transection, with cell-survival and tract-tracing endpoints
The reduction in lean body mass does not entirely equate to a decrease in skeletal muscle mass
While ER imaging (ultrasound, CT, or HIDA scans) can help document gallbladder issues, operative and pathology reports are often stronger evidence in linking the injury to GLP1 exposure
It is administered subcutaneously once a week and has been proven effective in improving glycemic control and reducing the risk of cardiovascular events in patients with type 2 diabetes
Expression and purification of Fab7F38GLP-1RsemaglutideGs Human GLP-1R (Arg24-Leu422) fragment fused with a N-terminal HA-FLAG-B2-HRV14-3C tags and C-terminal HPC4-HRV14-3C-10 His tags was synthesized and inserted into a modified pFastBac-1 vector (BamHI/HindIII sites) under the polh promoter (Genewiz) (see primers in Supplementary Table 2)